奥浦迈

688293 SSE 证监会行业分类 M73研究和试验发展

Key Metrics

Market Cap

5.8B ($848.6M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

297.0M

Net Income

20.2M

Gross Margin

N/A

Op. Margin

12.3%

Net Margin

6.8%

ROE

1.0%

ROA

0.9%

D/E

0.09

Dividend Yield

N/A

EPS

0.18

Current Ratio

13.02

Price History

Company Info

Industry	M73研究和试验发展
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers cell culture media and feed supplements, such as OPM's CHO-Platform, OPM-293 Platform, and VegaCHO media and feeds, as well as customized cell culture media development services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development, cell banking, upstream process development, downstream process development, formulation development, and quality control and product characterization of biologics. The company was ...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 奥浦迈

Ticker	688293
Exchange	SSE
Sector	证监会行业分类
Industry	M73研究和试验发展